Shengda Bio-Pharm Reports Net Profits of RMB 21.68 Million for the First Three Quarters of 2024, Up 687.86% Year-on-Year-EFFAMALL

Home Page / Effamall Information

Shengda Bio-Pharm Reports Net Profits of RMB 21.68 Million for the First Three Quarters of 2024, Up 687.86% Year-on-Year

Published on： Invalid date Categories： Author：